Detalhe da pesquisa
1.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750115
2.
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary.
Future Oncol
; 20(3): 113-120, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010044
3.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612799
4.
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
Curr Oncol Rep
; 25(8): 913-922, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249833
5.
Cellular Therapy in NSCLC: Between Myth and Reality.
Curr Oncol Rep
; 25(10): 1161-1174, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646900
6.
Neoadjuvant Immunotherapy: A Promising New Standard of Care.
Int J Mol Sci
; 24(14)2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511609
7.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675262
8.
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer
; 128(16): 3067-3079, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727053
9.
International Survey on Frailty Assessment in Patients with Cancer.
Oncologist
; 27(10): e796-e803, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905085
10.
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy.
Cancer Invest
; 40(5): 406-412, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409906
11.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255605
12.
[Patient involvement in oncology research - Development of a reference framework in French-speaking Switzerland]. / Implication des patients dans la recherche en oncologie - Développement d'un cadre de référence en Suisse romande.
Rev Med Suisse
; 18(775): 621-625, 2022 Mar 30.
Artigo
em Francês
| MEDLINE | ID: mdl-35353459
13.
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Cancer Immunol Immunother
; 70(5): 1255-1262, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130956
14.
The Role and Impact of Minimal Residual Disease in NSCLC.
Curr Oncol Rep
; 23(12): 136, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735646
15.
A New Generation of Vaccines in the Age of Immunotherapy.
Curr Oncol Rep
; 23(12): 137, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735649
16.
[Non-small cell lung cancer: a target biology]. / Cancer pulmonaire non à petites cellules : une biologie prête à cibler.
Rev Med Suisse
; 17(739): 967-973, 2021 May 19.
Artigo
em Francês
| MEDLINE | ID: mdl-34009755
17.
The METeoric rise of MET in lung cancer.
Cancer
; 126(22): 4826-4837, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888330
18.
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.
Cancer Immunol Immunother
; 69(8): 1605-1613, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32307579
19.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Acta Oncol
; 59(9): 1058-1063, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762415
20.
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Int J Mol Sci
; 21(17)2020 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878298